Penumbra, Inc Asset Acquisition Consideration Transferred Transaction Cost
Penumbra, Inc (PEN) had Asset Acquisition Consideration Transferred Transaction Cost of $1.00 million as of 2023-09-29, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Asset Acquisition, Consideration Transferred
us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost · last filed 2026-02-25
- 2023-09-29: Asset Acquisition Consideration Transferred Transaction Cost $1.00M.
| Period end | Asset Acquisition Consideration Transferred Transaction Cost |
|---|---|
| 2023-09-29 | $1.00M 10-K · filed 2026-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |